AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

SGRY · NASDAQ · Medical - Care Facilities

Surgery Partners (SGRY)

Operates physician-partnered surgery centers and short-stay hospitals for planned procedures.

$14.65

vs last close−1.15 (−7.27%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	674	735	717	762	770	864	776	826	822	885	811	849
Cost of revenue	508	542	562	583	593	631	614	631	626	673	689	659
Gross profit	166	194	155	179	178	234	162	196	195	212	122	190
	83	92	79	94	117	107	100	84	90	102	39	88
	37	21	33	40	29	36	36	36	324	127	141	36
General & administrative	37	21	33	40	29	36	36	36	324	127	141	36
Other expenses	46	71	46	54	87	71	64	48	−234	−25	−101	52
Operating income	83	101	76	85	61	127	62	112	106	110	82	102
	−50	−49	−47	−52	−50	−53	−62	−68	−75	−68	−86	−70
Interest expense	50	49	47	52	50	53	62	68	335	193	71	70
Other non-operating income	0	0	0	0	0	0	0	0	−260	−125	15	0
Income before tax	33	53	29	33	11	74	0	44	31	43	−3	32
Income tax expense	3	6	4	5	5	121	0	−1	6	14	−1	3
Net income from continuing operations	30	47	24	28	6	−47	0	45	25	29	−2	30
Net income	−5	−1	−12	−16	−32	−109	−38	−3	−23	−15	−36	−15
EPS, basic	$0.29	−$0.01	−$0.10	−$0.12	−$0.25	−$0.86	−$0.30	−$0.02	−$0.18	−$0.11	−$0.28	−$0.12
EPS, diluted	$0.29	−$0.01	−$0.10	−$0.12	−$0.25	−$0.86	−$0.30	−$0.02	−$0.18	−$0.11	−$0.28	−$0.12
Weighted average shares, basic	126	126	126	126	126	126	127	127	127	127	128	129
Weighted average shares, diluted	126	126	126	126	126	126	127	127	127	127	128	129
EBITDA	112	133	110	120	111	161	98	152	405	295	106	141
Depreciation & amortization	29	31	34	35	50	34	36	40	40	60	39	39
EBIT	83	101	76	85	61	127	62	112	366	235	67	102